Classification of primary liver cancer with immunosuppression mechanisms and correlation with genomic alterations
2020 · EBioMedicine · 90 citations
https://doi.org/10.1016/j.ebiom.2020.102659
S
Shu Shimada
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
90
Papers
2.1K
Citations
25
h-index
35
i10-index
Shu Shimada is an academic researcher. The author has contributed to research in topics: Ferroptosis and cancer prognosis & RNA modifications and cancer & Epigenetics and DNA Methylation. The author has an h-index of 25, co-authored 77 publications.
ORCID: 0000-0002-4962-0636Papers by this author
worksSeptin 9_i2 is downregulated in tumors, impairs cancer cell migration and alters subnuclear actin filaments
2017 · Scientific Reports · 58 citations
https://doi.org/10.1038/srep44976
Circulating microRNAs as biomarkers for early detection of diffuse-type gastric cancer using a mouse model
2013 · British Journal of Cancer · 53 citations
https://doi.org/10.1038/bjc.2013.30
Intrinsic activation of β-catenin signaling by CRISPR/Cas9-mediated exon skipping contributes to immune evasion in hepatocellular carcinoma
2021 · Scientific Reports · 29 citations
https://doi.org/10.1038/s41598-021-96167-0
Tumor suppressor functions of DAXX through histone H3.3/H3K9me3 pathway in pancreatic NETs
2018 · Endocrine Related Cancer · 21 citations
https://doi.org/10.1530/erc-17-0328
DEPDC5 deficiency contributes to resistance to leucine starvation via p62 accumulation in hepatocellular carcinoma
2018 · Scientific Reports · 20 citations
https://doi.org/10.1038/s41598-017-18323-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat